Search Results for “cancer” – Page 55 – media

Bayer receives approval in China for Stivarga® (regorafenib) for the second-line systemic Treatment of liver cancer

Approval based on data from the Phase III RESORCE study where Stivarga® (regorafenib) demonstrated significant improvement in overall survival in hepatocellular carcinoma (HCC) patients previously treated with Nexavar® (sorafenib)
- Source: investor.bayer
- 690
- December 14, 2017
Bayer CFDA hepatocellular carcinoma Nexavar® Stivarga®
FDA Grants Genentech’s Avastin Full Approval for Most Aggressive Form of Brain Cancer

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced that the U.S. Food and Drug Administration (FDA) has granted full approval for Avastin® (bevacizumab) for the treatment of adults with glioblastoma that progressed following prior therapy (referred to as recurrent disease). Avastin was previously granted provisional approval in this setting under the FDA's accelerated approval program.
- Source: Gene
- 555
- December 8, 2017
FDA Genentech New Approvals Roche
Researchers show aspirin added to cancer drug improves effectiveness

Adding aspirin to some existing cancer drugs could increase their effectiveness against a group of tumours resistant to treatment, new research has shown.
- Source: medicalxpress
- 589
- December 5, 2017
aspirin cancer colorectal lung pancreatic Researches
FDA approves first biosimilar for the treatment of certain breast and stomach cancers

The US Food and Drug Administration (FDA) today approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients with breast or metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma) whose tumors overexpress the HER2 gene (HER2+). Ogivri is the first biosimilar approved in the US for the treatment of breast cancer or stomach cancer and the second biosimilar approved in the US for the treatment of cancer.
- Source: mdlinx
- 624
- December 5, 2017
breast cancer FDA herceptin New Approvals Ogivri stomach cancer
Mouth bacteria linked to esophageal cancer

An analysis of microbes sampled from the mouths of more than 120,000 people has found that two types of bacteria that lead to gum disease are also linked to higher risk of esophageal cancer.
- Source: medicalnewstoday
- 613
- December 4, 2017
cancer mouth bacteria Researches
Gottlieb Says Faster Cancer Drug Approvals Coming for Secondary Indications

US Food and Drug Administration (FDA) Commissioner Scott Gottlieb and NIH Director Francis Collins testified on Thursday before the House Energy & Commerce Committee on how their agencies have worked to implement provisions from the 21st Century Cures Act passed and signed by President Barack Obama a month before he left office.
- Source: raps.org
- 682
- December 4, 2017
cancer FDA NIH Policy
Zika Virus Kills Brain Cancer Stem Cells MEDICINE & HEALTH

While Zika virus causes devastating damage to the brains of developing fetuses, it one day may be an effective treatment for glioblastoma, a deadly form of brain cancer. New research from Washington University School of Medicine in St. Louis and the University of California San Diego School of Medicine shows that the virus kills brain cancer stem cells, the kind of cells most resistant to standard treatments.
- Source: scienmag
- 569
- November 28, 2017
brain cancer glioblastoma Researches
Are These Four Viruses Present in Breast Tissue before Breast Cancer? – Medical News Bulletin

A study examines the association between viruses and breast cancer by examining the presence of the four viruses in normal breast tissue and after cancer development.
- Source: medicalempires
- 529
- November 24, 2017
breast cancer Researches
Encouraging oxygen’s assault on iron may offer new way to kill lung cancer cells

Blocking the motion of a key protein frees oxygen to injury iron-dependent proteins in lung and breast cancer cells, slowing their enlargement and making them more straightforward to kill.
- Source: medical-newspaper
- 553
- November 24, 2017
breast cancer lung cancer Researches
How do cancer cells start to spread? Study sheds light

Metastatic cancer is responsible for the vast majority of cancer deaths, but our limited understanding of how metastasis begins makes finding ways to stop it hugely challenging. A new study may provide some insight, however.
- Source: medicalnewstoday
- 472
- November 23, 2017
cancer Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.